A Case of Right Atrial Thrombosis in a Newborn Infant
The risk of neonatal thromboses consists in the development of severe complications (pulmonary artery thromboembolia) and a patient’s death. The intensity of complications can vary from asymptomatic to fatal thromboses. With the implementation of ultrasound technique into diagnostics, thromboses in newborn infants are recorded more frequently. We described a case of the right atrial thrombosis in a newborn infant. Heparin therapy every 7 days under echocardiography and hemostasis indices control was chosen as the treatment modality. Heparin was administered for 11 days till complete thrombolysis.
- Van Ommen C.H., Heijboer H., Buller H.R., Hirasing R.A., Heijmans H.S., Peters M. Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands. J Pediatr 2001; 139: 676–681.
- Ovanesov M.V., Lopatina E.G., Saenko E.L., Ananyeva N.M., Ul’yanova L.I., Plyushch O.P., Butilin A.A., Ataullakhanov F.I. Effect of factor VIII on tissue factor-initiated spatial clot growth. Thromb Haemost 2003; 89: 235–242.
- Lane A.D, Grant J.P. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000; 95(5): 1517–1532.
- Ananth V.C., Elsasser A.D., Kinzler L.W., et al. Polymorphisms in methionine synthase reductase and betaine-homocysteine Smethyltransferase genes: risk of placental abruption. Molecular Genetics and Metabolism 2007; 91: 104–110.
- Salomon O., Rosenberg N., Zivelin A., Steinberg D.M., Kornbrot N., Dardik R., Seligsohn U. Methionine synthase A2756G and metylenetetrahydrofolate reductase A1298C polymorphisms are not risk factors for idiopathic venous thromboembolism. Hematology J 2001; 2: 38–41.
- Sukhanova G.A., Barkagan Z.S., Kotovshchikova E.F., et al. Tromboticheskie mezenkhimal’nye displazii i ikh svyaz’ s drugimi trombofiliyami [Thrombotic mesenchimal dysplasias and their associatiom with other thrombophilias]. Gematologiya i transfuziologiya — Hematology and Transfusiology 2003; 6: 13–14.
- Maynard G., Stein J. Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis 2010 Feb; 29(2): 159–166.